Aurobindo Pharma's profit in April-June quarter may jump 29.6 percent year-on-year to Rs 560.3 crore and revenue is seen rising 15 percent to Rs 3,810.7 crore, according to average of estimates of analysts polled by CNBC-TV18.
first published: Aug 23, 2016 10:33 am
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty bulls take it to new highs after Fed outcome? | Opening Bell
Live: Positive start to November series, Nifty sustains above 26,000 | Closing Bell
Live: Will Nifty continue to chase 26,000? | Opening Bell
Stock Market LIVE: Sensex, Nifty Off Day’s Lows | F&O Expiry Sparks Volatility | Closing Bell
